Similarly, knockdown of NRP1 showed an increase in the radiosensitivity of human non-small-cell lung cancer cells (NSCLC), not only in vitro, but also in vivo, perhaps via the VEGF-PI3K-NF-kappaβ pathway [42]. Here, NRP1 is linked to non-small cell lung carcinoma.